Sign in Subscribe
Pharmaceutical industry

Biotech-Pharma Oncology Partnerships Take Center Stage

Strategic Insights

— 1 min read

As the fight against cancer gains momentum, the partnership between biotechnology and pharmaceutical industries is evolving into a powerful alliance network. This shift in strategy allows companies to focus on their core strengths, build networks, and generate profit-making ventures to support their own drug development initiatives. The Biotech-Pharma Oncology Partnerships Executive conference, scheduled for February 23-24, 2004, will delve into these emerging trends and predominant strategies adopted by biotech and pharma companies in their quest to develop oncology products.

Key Takeaways:

  • The biotech-pharma partnership model is shifting towards an alliance network of specialty companies, where each player contributes to the end product and shares in the revenues.
  • By focusing on areas of core expertise, biotech and pharma companies can build networks of alliances to bring products to market more efficiently.
  • Companies no longer need to be mini-pharmaceutical firms to be profitable and successful; they can thrive by focusing on essential areas.
  • The conference will feature a Biotech-Pharmaceutical Oncology Partnership Debate, facilitated by industry leaders Lloyd Segal and Steven Strand, and include panelists from leading biotech and pharma companies such as Celgene, AstraZeneca, and Novartis-Oncology.
  • The partnerships will not only facilitate the development of oncology products but also generate profit-making enterprises to support other activities.
  • The 20th-century business model of setting up a company that won't report earnings for 10 to 15 years is being replaced by a more agile and profitable approach.
  • The conference will examine the emerging trends and predominant strategies for partnerships in the biotech and pharma industries.

Statistics:

  • The conference will take place on February 23-24, 2004.
  • The Biotech-Pharma Oncology Partnerships Executive conference is being organized by CBI.
  • The conference features a debate and panel discussion with industry leaders.

Sources:

  • "Attend CBI's Biotech-Pharma Oncology Partnerships Executive conference, February 23-24, 2004 and hear best practices and deal making presentations from the C-level and Senior Executives from biotechnology and pharmaceutical companies." (PRNewswire)
  • The Center for Business Intelligence (CBNet) (http://www.cbinet.com/)
  • Contact: Press - Kim Hunter of The Center for Business Intelligence, 1-800-817-8601, Fax - +1-781-939-2495, cbireg@cbinet.com

Read more